Abstract:p53‐knockout mice were more susceptible to radiation‐induced gastrointestinal (GI) toxicity and had a significantly shorter survival than p53‐wild‐type mice following radiation; however, antibiotics administration improved the survival and conferred protection against GI toxicity, thus linking p53 to the gut microbiome. Furthermore, p53‐knockout mice were also discovered to have a different gut microbiota profile compared with p53‐wild‐type mice. Two innate immunity‐related genes, Mbl2 and Lcn2, both having antimicrobial activity, were found directly transactivated by p53. This elucidates p53's involvement in shaping the gut microbiome through its downstream targets in the innate immune system and protecting the intestinal barrier. p53 is a key tumor suppressor mutated in half of human cancers. In recent years, p53 was shown to regulate a wide variety of functions. From the transcriptome analysis of 24 tissues of irradiated mice, we identified 553 genes markedly induced by p53. Gene Ontology (GO) enrichment analysis found that the most associated biological process was innate immunity. 16S rRNA‐seq analysis revealed that Akkermansia, which has anti‐inflammatory properties and is involved in the regulation of intestinal barrier integrity, was decreased in p53‐knockout (p53−/−) mice after radiation. p53−/− mice were susceptible to radiation‐induced GI toxicity and had a significantly shorter survival time than p53‐wild‐type (p53+/+) mice following radiation. However, administration of antibiotics resulted in a significant improvement in survival and protection against GI toxicity. Mbl2 and Lcn2, which have antimicrobial activity, were identified to be directly transactivated by p53 and secreted by liver into the circulatory system. We also found the expression of MBL2 and LCN2 was decreased in liver cancer tissues with p53 mutations compared with those without p53 mutations. These results indicate that p53 is involved in shaping the gut microbiome through its downstream targets related to the innate immune system, thus protecting the intestinal barrier.

Radiation-induced Genetic Instability in Vivo Depends on P53 Status

Chromosome Instability Contributes To Loss Of Heterozygosity In Mice Lacking P53

p53 dynamics vary between tissues and are linked with radiation sensitivity

Reduced Apoptosis And Increased Deletion Mutations At Aprt Locus In Vivo In Mice Exposed To Repeated Ionizing Radiation

Mutagenesis in Vivo in T Cells of P21-Deficient Mice

Protective Effects of p53 Regulatory Agents Against High-LET Radiation-Induced Injury in Mice

Regulation of the innate immune response and gut microbiome by p53

Effects of Genetic Variation on Urinary Small Molecule Signatures of Mice after Exposure to Ionizing Radiation: A Study of p53 Deficiency

Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities

The Trp53 Delta Proline (trp53δp) Mouse Exhibits Increased Genome Instability and Susceptibility to Radiation-Induced, but Not Spontaneous, Tumor Development.

p53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis

P53 and P21(waf1) Are Recruited to Distinct PML-Containing Nuclear Foci in Irradiated and Nutlin-3a-Treated U2OS Cells

The Role of Nucleophosmin/b23 in Radiation-Induced Chromosomal Instability in Human Lymphoblastoid Cells of Different P53 Genotypes

An Abnormality in the P53 Pathway Following Gamma-Irradiation in Many Wild-Type P53 Human Melanoma Lines

P53 Gene Mutations Are Associated with Decreased Sensitivity of Human Lymphoma Cells to DNA Damaging Agents.

Chromosome Stability, in the Absence of Apoptosis, is Critical for Suppression of Tumorigenesis in Trp53 Mutant Mice

Differential Effects of P53 on Bystander Phenotypes Induced by Gamma Ray and High Let Heavy Ion Radiation

Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas

Quantitative Proteomics Analysis of the Effects of Ionizing Radiation in Wild Type and P53k317r Knock-in Mouse Thymocytes

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells